1. Diabetology: Feature Papers 2022.
- Author
-
Clifton, Peter and Clifton, Peter
- Subjects
Clinical & internal medicine ,Medicine ,COVID-19 ,Chronic Care Model ,DKA ,DM ,DSMES ,HbA1c ,NAFLD ,National DPP ,SARS-CoV-2 ,angiotensin-converting enzyme 2 ,beta cell preservation ,chronic disease ,clinical detection ,continuous glucose monitoring ,coronavirus disease 2019 ,cytokine storm ,diabetes ,diabetes mellitus ,diabetic ketoacidosis ,frailty ,fructose ,healthcare system of Pakistan ,hyperglycemia ,inflammation ,injection technique ,innate immunity ,insulin ,insulin therapy ,key informant interviews ,lipodystrophy ,lipohypertrophy ,liver enzymes ,management ,mortality ,nocturia ,obesity ,obstructive sleep apnoea ,older people ,pancreatic β-cell damage ,patients' quality of life ,pediatrics ,polysomnography ,prediabetes ,prevention of type 2 diabetes ,provider experiences ,recommendations ,rehabilitation ,rhenium (V) compound ,sarcopenia ,self-management of type 2 diabetes ,severe acute respiratory syndrome coronavirus 2 ,sodium glucose co-transporter 2 (SGLT2) inhibitors ,sodium intake ,telehealth ,telemedicine ,thioredoxin-interacting protein (TXNIP) ,triglycerides ,type 1 diabetes ,type 2 diabetes ,verapamil - Abstract
Summary: As Editor-in-Chief of the journal Diabetology, I am pleased to announce that the Special Issue "Diabetology: Feature Papers 2022" has now been published as a reprint. Diabetology (ISSN 2673-4540) is an international, peer-reviewed scientific open access journal that provides an advanced forum for studies related to the epidemiology, etiology, pathophysiology, pathogenesis, management, complications, and prevention of diabetes, including the molecular, biochemical, and physiological aspects of diabetes. In this Special Issue, "Feature Papers", we aimed to publish outstanding contributions in the main fields covered by the journal, which will make a great contribution to the community. This reprint covers the whole spectrum of diabetology from risk screening, risk markers, pathways of disease in type 1 diabetes and insulin treatment, and management of the disease and comorbidities.